These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25834499)

  • 1. Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
    Gedik H; Şimşek F; Kantürk A; Yıldırmak T; Arıca D; Aydın D; Yokuş O; Demirel N
    Afr Health Sci; 2014 Dec; 14(4):899-905. PubMed ID: 25834499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
    Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
    J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies.
    Ümit EG; Kuloğlu F; Demir AM
    Turk J Haematol; 2017 Mar; 34(1):89-92. PubMed ID: 27531123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance.
    Zacharioudakis IM; Zervou FN; Ziakas PD; Rice LB; Mylonakis E
    Am J Kidney Dis; 2015 Jan; 65(1):88-97. PubMed ID: 25042816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
    Gedik H; Yildirmak T; Simsek F; Kanturk A; Aydýn D; Anca D; Yokus O; Demirel N
    Afr Health Sci; 2013 Jun; 13(2):362-8. PubMed ID: 24235937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country.
    Ulu-Kilic A; Özhan E; Altun D; Perçin D; Güneş T; Alp E
    Am J Infect Control; 2016 Apr; 44(4):e45-9. PubMed ID: 26775930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
    Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
    Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
    Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
    Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
    Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
    Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies.
    Almyroudis NG; Osawa R; Samonis G; Wetzler M; Wang ES; McCarthy PL; Segal BH
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):398-403. PubMed ID: 26750087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation.
    Ford CD; Gazdik Stofer MA; Coombs J; Lopansri BK; Webb BJ; Motyckova G; Petersen FB
    Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1055-1061. PubMed ID: 28724453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus.
    Zachariah P; Freedberg DE
    J Hosp Infect; 2019 Jul; 102(3):343-346. PubMed ID: 30641098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
    Zhou MJ; Li J; Salmasian H; Zachariah P; Yang YX; Freedberg DE
    J Hosp Infect; 2019 Jan; 101(1):69-75. PubMed ID: 30026006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of Four-Year Rectal Vancomycin-Resistant Enterococci Surveillance in a Pediatric Hematology-Oncology Ward: From Colonization to Infection.
    Aktürk H; Sütçü M; Somer A; Karaman S; Acar M; Ünüvar A; Anak S; Karakaş Z; Özdemir A; Sarsar K; Aydın D; Salman N
    Turk J Haematol; 2016 Sep; 33(3):244-7. PubMed ID: 27094847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
    Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
    Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.
    Meschiari M; Kaleci S; Monte MD; Dessilani A; Santoro A; Scialpi F; Franceschini E; Orlando G; Cervo A; Monica M; Forghieri F; Venturelli C; Ricchizzi E; Chester J; Sarti M; Guaraldi G; Luppi M; Mussini C
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):126. PubMed ID: 37957773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
    Bossaer JB; Hall PD; Garrett-Mayer E
    Support Care Cancer; 2010 Feb; 19(2):231-7. PubMed ID: 20069435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
    Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
    Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
    Popiel KY; Miller MA
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10-year trends in vancomycin-resistant enterococci among allogeneic hematopoietic cell transplant recipients.
    MacAllister TJ; Stohs E; Liu C; Bryan A; Whimbey E; Phipps A; Pergam SA
    J Infect; 2018 Jul; 77(1):38-46. PubMed ID: 29746941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.